The DOI matches its Crossref record; 189 of the 192 references it cites were found in a registry or an index; 119 of the 211 sources its claims cite were checked for support.
Mitochondrial Oxidative and Nitrosative Stress and Alzheimer Disease
Open accessAbstract
Oxidative and nitrosative stress are widely recognized as critical factors in the pathogenesis and progression of Alzheimer disease (AD) and its earlier stage, amnestic mild cognitive impairment (MCI). A major source of free radicals that lead to oxidative and nitrosative damage is mitochondria. This review paper discusses oxidative and nitrosative stress and markers thereof in the brain, along with redox proteomics, which are techniques that have been pioneered in the Butterfield laboratory. Selected biological alterations in-and oxidative and nitrosative modifications of-mitochondria in AD and MCI and systems of relevance thereof also are presented. The review article concludes with a section on the implications of mitochondrial oxidative and nitrosative stress in MCI and AD with respect to imaging studies in and targeted therapies toward these disorders. Taken together, this review provides support for the notion that brain mitochondrial alterations in AD and MCI are key components of oxidative and nitrosative stress observed in these two disorders, and as such, they provide potentially promising therapeutic targets to slow-and hopefully one day stop-the progression of AD, which is a devastating dementing disorder.
Overview
CoChat Summary
TL;DR
This is a review arguing that mitochondrial oxidative and nitrosative stress are central to Alzheimer disease (AD) and amnestic mild cognitive impairment (MCI), and that mitochondria may be promising therapeutic targets. It synthesizes evidence from brain, cell, animal, and peripheral-cell studies, including redox proteomics, imaging, and mitochondria-targeted interventions.
Key findings
- The review states that oxidative/nitrosative stress and mitochondrial dysfunction are widely recognized as critical in AD and MCI, and that mitochondria are a major source of the free radicals that cause this damage.
- Redox proteomics identified oxidized/nitrated mitochondrial proteins in AD and MCI brain, including aconitase, malate dehydrogenase, ATP synthase, lactate dehydrogenase-B, MnSOD, p53, VDAC1, EF-Tu, HSP70, and HSP90; the paper reports that activities of LDH, aconitase, and ATP synthase are significantly decreased, while MDH activity is significantly increased.
- In mitochondria isolated from lymphocytes of MCI and AD patients, protein-bound carbonyls, 3-NT, and HNE were significantly increased and correlated with elevated Aβ, decreased small-molecule antioxidants, and decreased cognitive test performance.
- The paper reports intervention-related findings including that Mdivi-1 protected against ROS production, loss of mitochondrial transport, synaptic damage, neuronal death, and stunted neuritic spines in untreated mice, while alpha-lipoic acid improved outcomes in dogs/rodents and a small clinical pilot study found slower cognitive decline; CoQ10 and MitoQ improved pathology or memory in transgenic mouse models.
Methods
- Narrative review of published studies on mitochondrial oxidative/nitrosative stress in AD and MCI, with emphasis on evidence from human brain, peripheral cells, in vitro systems, and animal models.
- Synthesizes studies using redox proteomics and related proteomic approaches to identify oxidatively/nitrosatively modified proteins and compare AD/MCI samples with controls.
- Integrates findings with imaging, metabolic, and therapeutic studies, including longitudinal and intervention reports mentioned in the text.
Limitations
- Not a primary empirical study; it is a review, so it does not present a single new sample, cohort, or original statistical analysis.
- The authors explicitly note that more research is needed in several places, including whether ketone supplementation is beneficial, whether apoE4-related astrocytic glucose-utilization differences occur in vivo, and how mitochondrial-targeted therapies should be developed.
- Evident from the text: many findings are drawn from heterogeneous prior studies across different models, tissues, and disease stages, so the review itself cannot establish causality or uniform effect sizes.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3 Redox proteomics identified oxidatively modified, mitochondrial proteins in brains from persons with Alzheimer disease or amnestic mild cognitive impairment. Proteins marked with a red star are oxidatively modified. Functional classes of oxidatively dysfunctional proteins include those related to: Glucose metabolism, i.e., lactate dehydrogenase (LDH), aconitase, malate dehydrogenase (MDH), ATP synthase; Export of anions (ATP, for example, has a decreased chance of export through voltage-dependent anion channel 1 (VDAC1) to drive neuronal function including the maintenance of mitochondrial potential); Free radical scavenging (MnSOD, which increases opportunities to cause further oxidative and nitrosative damage to mitochondria); mitochondrial protein synthesis (EF-Tu, which would lead to altered levels of key proteins needed to assemble into functional inner membrane resident electron transport complexes and thereby decrease ATP levels); and chaperone and transport function for the import of nuclear-encoded proteins into mitochondria (heat shock protein 70 (HSP70); heat shock protein 90 (HSP90), which also could contribute to altered protein levels of needed electron transport chain [(ETC) complexes and other key proteins]. See text for further details.](https://figures.cochat.ai/paper-figures/ac99b96fdd8e48f69d70649bcfc76e38/mitochondrial-oxidative-and-nitrosative-stress-and-alzheimer-disease-figure-3.jpg)

Verification
Claims the paper makes
73 Valid · 5 Not valid · 30 Not checked · 20 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“elegant research from Mahley’s laboratory demonstrated in Neuro-2a neuronal cells expressing stable isoforms of apolipoprotein E (apoE), i.e., apoE2, apoE3, or apoE4, with the latter a major risk factor for developing AD, that apoE4 is excessively produced by damaged neurons [31].”
§ Mitochondrial Oxidative and Nitrosative Stress and Alzheimer Disease > 3. Selected Biological Alterations in AD Mitochondria
What the sources say
- Partly supportedcites [31] Huang, 2014, Apolipoprotein E: Structure and function in lipid metabolism, neurobiology, and Alzheimer’s diseases, Neurobiol. Dis. sourceExperimental — accuracy not yet measured
In “Synthesis of ApoE in Different Tissues and Cells” (page unavailable), the review reports that hippocampal and cortical neurons express apoE in response to injury. In “ApoE4 proteolysis and neurotoxicity” (page unavailable), it hypothesizes that injury enhances neuronal apoE expression, but does not establish that damaged neurons excessively produce apoE4 specifically. Its discussion of apoE-transfected Neuro-2a cells concerns neurite extension, not production by damaged neurons. (LLM, conf=0.88)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“With the NO2 functionality on Tyr, tyrosine phosphorylation by tyrosine kinases, including receptor tyrosine kinases, is inhibited due to steric interference of the NO2 group with the active site of the enzyme.”
§ Mitochondrial Oxidative and Nitrosative Stress and Alzheimer Disease > 2. Mitochondria and Oxidative and Nitrosative Stress
What the sources say
- Could not verifycites [8] Butterfield, 2019, Oxidative stress, glucose dysmetabolism and Alzheimer disease, Nat. Rev. Neurosci. sourceExperimental — accuracy not yet measured
The 'Oxidative Damage is relevant to AD' section reports elevated 3-nitrotyrosine, and 'Proteostasis Abnormalities in AD' discusses receptor tyrosine kinases. Neither passage links tyrosine nitration to inhibited phosphorylation or attributes such inhibition to steric interference by an NO2 group. Searches for that mechanism and for nitration-related kinase inhibition found no supporting passage; page numbers were unavailable in our copy. (LLM, conf=0.76)
- Not checked — no full text of the sourcecites [13] Halliwell, B., and Gutteridge, J.M.C. (2015). Free Radicals in Biology & Medicine, Oxford University Press. [5th ed.]. source
- Not checked — no full text of the sourcecites [29] Radi, 2018, Oxygen radicals, nitric oxide, and peroxynitrite: Redox pathways in molecular medicine, Proc. Natl. Acad. Sci. USA source
- Partly supportedcites [30] Bartesaghi, 2017, Tyrosine-nitrated proteins: Proteomic and bioanalytical aspects, Antioxid. Redox Signal. sourceExperimental — accuracy not yet measured
The Introduction says that adding a bulky NO2 group to a relevant tyrosine residue can impose steric restrictions and inhibit tyrosine phosphorylation. It does not specifically say that the inhibition results from interference with a tyrosine kinase’s active site, or identify receptor tyrosine kinases in this account. (LLM, conf=0.86)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The former leads to the incorporation of carbonyl functionalities in proteins and alterations in protein conformation (and normally loss of function as a consequence) [8,22,23,24]”
§ Mitochondrial Oxidative and Nitrosative Stress and Alzheimer Disease > 2. Mitochondria and Oxidative and Nitrosative Stress
What the sources say
- Partly supportedcites [8] Butterfield, 2019, Oxidative stress, glucose dysmetabolism and Alzheimer disease, Nat. Rev. Neurosci. sourceExperimental — accuracy not yet measured
The ‘Oxidative Damage is relevant to AD’ section identifies protein carbonyls as markers of oxidative damage, and ‘Contribution of oxidative damage’ says oxidative modification almost always decreases the activity of the glucose-metabolism enzymes it discusses. The concluding remarks link changed protein conformation and reduced activity to reactive aldehydes from lipid peroxidation. Our copy does not establish the claimed sequence specifically for hydroxyl-radical reactions with proteins. (LLM, conf=0.82)
- Not checked — no full text of the sourcecites [22] Butterfield, 1997, Protein oxidation processes in aging brain, Adv. Cell Aging Gerontol. source
- Not checked — no full text of the sourcecites [23] Tramutola, 2017, Oxidative stress, protein modification and Alzheimer disease, Brain Res. Bull. source
- Partly supportedcites [24] Ren, 2019, Profiles of brain oxidative damage, ventricular alterations, and neurochemical metabolites in the striatum of PINK1 Kkockout rats as functions of age and gender: Relevance to parkinson disease, Free Radic. Biol. Med. sourceExperimental — accuracy not yet measured
The Methods (Slot blot assay; page unavailable) measure protein carbonyls, and the Discussion (page unavailable) treats them as biomarkers of oxidative damage. The paper does not say that hydroxyl radicals incorporate carbonyl groups into proteins or that this changes protein conformation and normally causes loss of function. (LLM, conf=0.82)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In that case, H2O2, which has zero dipole moments and is therefore neutral and can diffuse into or through bilayers, can be decomposed to hydroxyl anion and the highly reactive hydroxyl free radical by Fe2+ or Cu+ in a process known as Fenton chemistry [8,13].”
§ Mitochondrial Oxidative and Nitrosative Stress and Alzheimer Disease > 2. Mitochondria and Oxidative and Nitrosative Stress
What the sources say
- Partly supportedcites [8] Butterfield, 2019, Oxidative stress, glucose dysmetabolism and Alzheimer disease, Nat. Rev. Neurosci. sourceExperimental — accuracy not yet measured
The section “Oxidative Damage is relevant to AD” describes OH• as highly reactive and H2O2 as less reactive. Our copy does not state that Fe2+ or Cu+ decomposes H2O2 into hydroxyl anion and hydroxyl radical through Fenton chemistry; searches for Fenton chemistry and the metal-ion reaction found no such passage. Page numbers were not available in the indexed copy. (LLM, conf=0.78)
- Not checked — no full text of the sourcecites [13] Halliwell, B., and Gutteridge, J.M.C. (2015). Free Radicals in Biology & Medicine, Oxford University Press. [5th ed.]. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“As electron flow occurs in the multiple redox-sensitive proteins within Complex I on the inner membrane, electron leak occurs, usually in the form of superoxide radical anion or the hydrogendioxide radical, elevating oxidative stress (Figure 1) [8,16,17].”
§ Mitochondrial Oxidative and Nitrosative Stress and Alzheimer Disease > 2. Mitochondria and Oxidative and Nitrosative Stress
What the sources say
- Could not verifycites [8] Butterfield, 2019, Oxidative stress, glucose dysmetabolism and Alzheimer disease, Nat. Rev. Neurosci. sourceExperimental — accuracy not yet measured
The “Oxidative Damage is relevant to AD” section lists superoxide among reactive oxygen species and defines oxidative stress, while “Contribution of oxidative damage” discusses oxidative damage in mitochondria (page numbers unavailable). Searches for Complex I, electron leakage, and superoxide production did not find a passage linking electron flow through Complex I to the claimed radicals or increased oxidative stress. (LLM, conf=0.72)
- Not checked — no full text of the sourcecites [16] Dhar, 2012, Manganese superoxide dismutase regulation and cancer, Free Radic. Biol. Med. source
- Not checked — no full text of the sourcecites [17] Nelson, 2006, The induction of human superoxide dismutase and catalase in vivo: A fundamentally new approach to antioxidant therapy, Free Radic. Biol. Med. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
58 more claims · 33 with their cited sources checked
Create a free account to see all 128 claims and to verify the 1 reference still open.
- It may state two separate claims as one. 52
- Probably not a substantial claim. 19
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Despite incredible efforts, there is still a lack of effective drugs for the treatment of AD.”
From Multi-target neuroprotective effects of herbal medicines for Alzheimer's disease (2022) · cites this paper as Butterfield and Boyd-Kimball, 2020
Experimental — accuracy not yet measuredIn the citing paper
“There are five drugs in clinic, including three cholinesterase inhibitors, that only provide palliative and supporting treatment (Butterfield and Boyd-Kimball, 2020;Zagórska and Jaromin, 2020;Gul et al., 2021).”
From Multi-target neuroprotective effects of herbal medicines for Alzheimer's disease (2022) · cites this paper as Butterfield and Boyd-Kimball, 2020
In the citing paper
“ROS and reactive nitrogen species (RNS) are capable of damaging and modifying several types of macromolecules, such as DNA, RNA, lipids, and proteins, compromising the normal functions of the cells (Butterfield and Boyd-Kimball, 2020; Persson et al., 2014).”
From Multi-target neuroprotective effects of herbal medicines for Alzheimer's disease (2022) · cites this paper as Butterfield and Boyd-Kimball, 2020
In the citing paper
“However, ChE inhibitors are not able to completely stop the progression of AD, and research should focus on the development of multi-target drugs able to counteract the decreased levels of ACh, protein misfolding and associated Aβ aggregation, hyperphosphorylation of tau protein, and oxidative stress (Butterfield and Boyd-Kimball, 2020;Zagórska and Jaromin, 2020).”
From Multi-target neuroprotective effects of herbal medicines for Alzheimer's disease (2022) · cites this paper as Butterfield and Boyd-Kimball, 2020
Citations
Cites
Free Radicals in Biology and Medicine
Halliwell, B., & Gutteridge, J. M. C. (2015) · doi:10.1093/acprof:oso/9780198717478.001.0001 · Cited by 8,990
Dementia prevention, intervention, and care
Livingston, G., Sommerlad, A., Orgeta, V., Costafreda, S. G., Huntley, J., Ames, D., Ballard, C., Banerjee, S., Burns, A., Cohen-Mansfield, J., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31363-6 · Cited by 6,072
2016 Alzheimer's disease facts and figures
Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069
Clinical and biomarker changes in dominantly inherited Alzheimer's disease
Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202753 · Cited by 3,814
Mitochondrial Fission, Fusion, and Stress
Youle, R. J., & van der Bliek, A. M. (2012) · Science · doi:10.1126/science.1219855 · Cited by 3,674 · cited 2×
“Among other functions, mitochondrial fission is involved in the regulation of mitophagy, apoptosis, and the cellular need for ATP [38].”
BackgroundSies, H., Berndt, C., & Jones, D. P. (2017) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061516-045037 · Cited by 3,520 · cited 1×
“Other mitochondrial-related antioxidant systems include, among others, thioredoxin [18], peroxiredoxin 4 [19], glutathione peroxidase 4 [20], and methionine sulfoxide reductase A [21].”
BackgroundWallace, D. C. (2005) · Annual Review of Genetics · doi:10.1146/annurev.genet.39.110304.095751 · Cited by 3,185 · cited 2×
“Mitochondrial oxidative stress is increased by the consumption of excess calories and, in turn, it leads to mitochondrial DNA damage [120], which has been described in an AD brain [169,170] in which base deletions correlate with complex IV deficiency in an AD hippocampus [171].”
Background2020 Alzheimer's disease facts and figures
(2020) · Alzheimer's & Dementia · doi:10.1002/alz.12068 · Cited by 2,353
Villemagne, V. L., Burnham, S., Bourgeat, P., Brown, B., Ellis, K. A., Salvado, O., Szoeke, C., Macaulay, S. L., Martins, R., Maruff, P., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70044-9 · Cited by 2,279
Cellular energy utilization and molecular origin of standard metabolic rate in mammals
Rolfe, D. F., & Brown, G. C. (1997) · Physiological Reviews · doi:10.1152/physrev.1997.77.3.731 · Cited by 2,021 · cited 1×
“The human brain comprises approximately 2% of body mass but consumes approximately 20% of daily oxygen intake [118].”
BackgroundOxidative stress, dysfunctional glucose metabolism and Alzheimer disease
Butterfield, D. A., & Halliwell, B. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-019-0132-6 · Cited by 1,954
Self-citationGlucose feeds the TCA cycle via circulating lactate
Hui, S., Ghergurovich, J. M., Morscher, R. J., Jang, C., Teng, X., Lu, W., Esparza, L. A., Reya, T., Zhan, L., Yanxiang Guo, J., et al. (2017) · Nature · doi:10.1038/nature24057 · Cited by 1,721 · cited 1×
“LDH is found preferentially in aerobic tissues [68] and allows neuronal mitochondria to utilize lactate imported by monocarboxylate transporter 2 (MCT2) as a fuel source by oxidation to pyruvate from which acetyl CoA can be produced and condensed into the tricarboxylic acid cycle at citrate synthase [67,69,70].”
BackgroundEpidemiology of Alzheimer disease
Reitz, C., Brayne, C., & Mayeux, R. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.2 · Cited by 1,675
Oxidative stress and mitochondrial dysfunction in Alzheimer’s disease
Wang, X., Wang, W., Li, L., Perry, G., Lee, H.-G., & Zhu, X. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.10.015 · Cited by 1,357
Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease.
Smith, C. D., Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Stadtman, E. R., Floyd, R. A., & Markesbery, W. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10540 · Cited by 1,296
MIND diet associated with reduced incidence of Alzheimer's disease
Morris, M. C., Tangney, C. C., Wang, Y., Sacks, F. M., Bennett, D. A., & Aggarwal, N. T. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.11.009 · Cited by 1,162
Oxygen radicals, nitric oxide, and peroxynitrite: Redox pathways in molecular medicine
Radi, R. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1804932115 · Cited by 1,142 · cited 6×
“With the NO2 functionality on Tyr, tyrosine phosphorylation by tyrosine kinases, including receptor tyrosine kinases, is inhibited due to steric interference of the NO2 group with the active site of the enzyme.”
BackgroundInfluentialMIND diet slows cognitive decline with aging
Morris, M. C., Tangney, C. C., Wang, Y., Sacks, F. M., Barnes, L. L., Bennett, D. A., & Aggarwal, N. T. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.04.011 · Cited by 1,115
Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid β-peptide
Butterfield, D. A., Drake, J., Pocernich, C., & Castegna, A. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02173-6 · Cited by 1,114 · cited 1×
“Aβ42 oligomers cause oxidative damage as mentioned above, and these oligomers also lead to synaptic dysfunction correlated with cognitive loss [8,9,26].”
BackgroundSelf-citationJack, C. R., Lowe, V. J., Weigand, S. D., Wiste, H. J., Senjem, M. L., Knopman, D. S., Shiung, M. M., Gunter, J. L., Boeve, B. F., Kemp, B. J., et al. (2009) · Brain · doi:10.1093/brain/awp062 · Cited by 1,099
Amyloid β-Protein Fibrillogenesis
Walsh, D. M., Hartley, D. M., Kusumoto, Y., Fezoui, Y., Condron, M. M., Lomakin, A., Benedek, G. B., Selkoe, D. J., & Teplow, D. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.36.25945 · Cited by 1,046
Butterfield, D. A., & Lauderback, C. M. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00794-3 · Cited by 1,001
Self-citationA critical appraisal of amyloid-β-targeting therapies for Alzheimer disease
Panza, F., Lozupone, M., Logroscino, G., & Imbimbo, B. P. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-018-0116-6 · Cited by 965
Molecular chaperones Hsp90 and Hsp70 deliver preproteins to the mitochondrial import receptor Tom70
Young, J. C., Hoogenraad, N. J., & Hartl, F. U. (2003) · Cell · doi:10.1016/s0092-8674(02)01250-3 · Cited by 915 · cited 2×
“stabilizing the unfolded state of the nascent proteins and thereby preventing aggregation, and they are required for transport of the protein into mitochondria through the translocase Tom70 [80].”
BackgroundAnstey, K. J., Cherbuin, N., Budge, M., & Young, J. (2011) · Obesity Reviews · doi:10.1111/j.1467-789x.2010.00825.x · Cited by 855
Mitochondria and Mitochondrial Cascades in Alzheimer’s disease
Swerdlow, R. H. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170585 · Cited by 850 · cited 6×
“Consequently, evidence consistent with the tenants of the Primary Mitochondrial Cascade hypothesis were obtained, suggesting, similar to that posited by Swerdlow, both cascades are in play in AD and MCI that coalesce in the brain as decreased glucose metabolism evidenced by altered glycolysis and mitochondria.”
BackgroundInfluentialApolipoprotein E: Structure and function in lipid metabolism, neurobiology, and Alzheimer’s diseases
Huang, Y., & Mahley, R. W. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.08.025 · Cited by 829
Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer’s disease
Small, G. W., Ercoli, L. M., Silverman, D. H. S., Huang, S.-C., Komo, S., Bookheimer, S. Y., Lavretsky, H., Miller, K., Siddarth, P., Rasgon, N. L., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.090106797 · Cited by 790
Hensley, K., Hall, N., Subramaniam, R., Cole, P., Harris, M., Aksenov, M., Aksenova, M., Gabbita, S. P., Wu, J. F., Carney, J. M., et al. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65052146.x · Cited by 779 · cited 1×
“GS is also oxidatively modified in both MCI and AD brain [44,54,59], likely resulting in the significantly decreased activity observed in AD brain [133,134].”
BackgroundSelf-citationMidlife vascular risk factor exposure accelerates structural brain aging and cognitive decline
Debette, S., Seshadri, S., Beiser, A., Au, R., Himali, J. J., Palumbo, C., Wolf, P. A., & DeCarli, C. (2011) · Neurology · doi:10.1212/wnl.0b013e318227b227 · Cited by 772
Diabetes mellitus and risk of dementia: A meta‐analysis of prospective observational studies
Gudala, K., Bansal, D., Schifano, F., & Bhansali, A. (2013) · Journal of Diabetes Investigation · doi:10.1111/jdi.12087 · Cited by 727
GPx4, Lipid Peroxidation, and Cell Death: Discoveries, Rediscoveries, and Open Issues
Maiorino, M., Conrad, M., & Ursini, F. (2018) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7115 · Cited by 703 · cited 1×
“Other mitochondrial-related antioxidant systems include, among others, thioredoxin [18], peroxiredoxin 4 [19], glutathione peroxidase 4 [20], and methionine sulfoxide reductase A [21].”
BackgroundDietary patterns and risk of dementia: The Three-City cohort study
Barberger-Gateau, P., Raffaitin, C., Letenneur, L., Berr, C., Tzourio, C., Dartigues, J. F., & Alpérovitch, A. (2007) · Neurology · doi:10.1212/01.wnl.0000278116.37320.52 · Cited by 700
Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease
Pugazhenthi, S., Qin, L., & Reddy, P. H. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.04.017 · Cited by 697
Neuropathology and Cognitive Impairment in Alzheimer Disease: A Complex but Coherent Relationship
Nelson, P. T., Braak, H., & Markesbery, W. R. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181919a48 · Cited by 643
Gottesman, R. F., Albert, M. S., Alonso, A., Coker, L. H., Coresh, J., Davis, S. M., Deal, J. A., McKhann, G. M., Mosley, T. H., Sharrett, A. R., et al. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2017.1658 · Cited by 633
Age, APOE and sex: triad of risk of Alzheimer’s disease.
Riedel, B. C., Thompson, P. M., & Brinton, R. D. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.03.012 · Cited by 627 · cited 1×
“While age, chromosomal sex, family history, and apoE genotype remain the primary risk factors for the development of AD [154,155], there are several controllable risk factors including obesity [156,157], hyperlipidemia [158,159], hypertension [160–163], type 2 diabetes [164–167], and sedentary lifestyle [168] that can…”
BackgroundGordon, B. A., Blazey, T. M., Su, Y., Hari-Raj, A., Dincer, A., Flores, S., Christensen, J., McDade, E., Wang, G., Xiong, C., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30028-0 · Cited by 602 · cited 2×
“While the deposition of Aβ occurs early in the progression of the disease [141], oligomeric Aβ rather than fibril Aβ is regarded as the toxic species of this peptide [143–146].”
BackgroundCytochrome oxidase deficiency in Alzheimer’s disease
Parker, W. D., Filley, C. M., & Parks, J. K. (1990) · Neurology · doi:10.1212/wnl.40.8.1302 · Cited by 598
Hertz, L., Peng, L., & Dienel, G. A. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600343 · Cited by 587 · cited 1×
“Glutamate functions as an excitatory neurotransmitter and a glutamate–glutamine cycle exists between astrocytes and neurons, allowing for the movement of anaplerotic carbon units and the sequestration of ammonia, which is neurotoxic [132].”
BackgroundCastegna, A., Aksenov, M., Aksenova, M., Thongboonkerd, V., Klein, J. B., Pierce, W. M., Booze, R., Markesbery, W. R., & Butterfield, D. A. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00914-0 · Cited by 581
Self-citationSolomon, A., Kivipelto, M., Wolozin, B., Zhou, J., & Whitmer, R. A. (2009) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000231980 · Cited by 557
Coskun, P. E., Beal, M. F., & Wallace, D. C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403649101 · Cited by 556
Reiman, E. M., Quiroz, Y. T., Fleisher, A. S., Chen, K., Velez-Pardo, C., Jimenez-Del-Rio, M., Fagan, A. M., Shah, A. R., Alvarez, S., Arbelaez, A., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70228-4 · Cited by 541
Evidence of increased oxidative damage in subjects with mild cognitive impairment
Keller, J. N., Schmitt, F. A., Scheff, S. W., Ding, Q., Chen, Q., Butterfield, D. A., & Markesbery, W. R. (2005) · Neurology · doi:10.1212/01.wnl.0000156156.13641.ba · Cited by 539
Self-citationMediterranean Diet, Cognitive Function, and Dementia: A Systematic Review
Lourida, I., Soni, M., Thompson-Coon, J., Purandare, N., Lang, I. A., Ukoumunne, O. C., & Llewellyn, D. J. (2013) · Epidemiology · doi:10.1097/ede.0b013e3182944410 · Cited by 521
Mosconi, L., Mistur, R., Switalski, R., Tsui, W. H., Glodzik, L., Li, Y., Pirraglia, E., De Santi, S., Reisberg, B., Wisniewski, T., et al. (2009) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-008-1039-z · Cited by 487
Sultana, R., Perluigi, M., & Butterfield, D. A. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.09.027 · Cited by 478
Self-citationDeficient glutamate tranport is associated with neurodegeneration in Alzheimer's disease
Masliah, E., Hansen, L., Alford, M., Deteresa, R., & Mallory, M. (1996) · Annals of Neurology · doi:10.1002/ana.410400512 · Cited by 476
Metabolic network failures in Alzheimer's disease: A biochemical road map
Toledo, J. B., Arnold, M., Kastenmüller, G., Chang, R., Baillie, R. A., Han, X., Thambisetty, M., Tenenbaum, J. D., Suhre, K., Thompson, J. W., et al. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.01.020 · Cited by 468 · cited 1×
“Metabolomic studies of MCI and AD CSF and plasma report altered levels of amino acids compared to controls, indicating that alterations in amino acid metabolism are present in AD [135,136].”
ResultLauderback, C. M., Hackett, J. M., Huang, F. F., Keller, J. N., Szweda, L. I., Markesbery, W. R., & Butterfield, D. A. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00451.x · Cited by 464 · cited 2×
“Aβ42 oligomers cause oxidative damage as mentioned above, and these oligomers also lead to synaptic dysfunction correlated with cognitive loss [8,9,26].”
BackgroundSelf-citationFarr, S. A., Poon, H. F., Dogrukol‐Ak, D., Drake, J., Banks, W. A., Eyerman, E., Butterfield, D. A., & Morley, J. E. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01580.x · Cited by 459 · cited 1×
“Alpha-lipoic acid is a cofactor for pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase, which are key components in glucose metabolism; when given to dogs and rodents, it decreases oxidative damage in the brain and improves cognition [149,150].”
BackgroundSelf-citationIn Vivo Evidence for Lactate as a Neuronal Energy Source
Wyss, M. T., Jolivet, R., Buck, A., Magistretti, P. J., & Weber, B. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.0415-11.2011 · Cited by 437 · cited 1×
“LDH is found preferentially in aerobic tissues [68] and allows neuronal mitochondria to utilize lactate imported by monocarboxylate transporter 2 (MCT2) as a fuel source by oxidation to pyruvate from which acetyl CoA can be produced and condensed into the tricarboxylic acid cycle at citrate synthase [67,69,70].”
BackgroundMcManus, M. J., Murphy, M. P., & Franklin, J. L. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.0552-11.2011 · Cited by 432 · cited 1×
“CoQ10 led to decreased Aβ pathology in aged transgenic mice with human AD presenilin-1 mutation, and in a different study, a quinonecontaining derivative of CoQ10 (MitoQ) that targets mitochondria, improved memory, and neuropathology in a transgenic mouse model of AD [152,153].”
BackgroundSelective distribution of lactate dehydrogenase isoenzymes in neurons and astrocytes of human brain
Bittar, P. G., Charnay, Y., Pellerin, L., Bouras, C., & Magistretti, P. J. (1996) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199611000-00001 · Cited by 423 · cited 1×
“LDH is found preferentially in aerobic tissues [68] and allows neuronal mitochondria to utilize lactate imported by monocarboxylate transporter 2 (MCT2) as a fuel source by oxidation to pyruvate from which acetyl CoA can be produced and condensed into the tricarboxylic acid cycle at citrate synthase [67,69,70].”
BackgroundRosenberg, A., Ngandu, T., Rusanen, M., Antikainen, R., Bäckman, L., Havulinna, S., Hänninen, T., Laatikainen, T., Lehtisalo, J., Levälahti, E., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.09.006 · Cited by 421 · cited 1×
“benefitted an at-risk population [181], even in APOEε4 carriers [182]; however, no significant differences in brain volume or cortical thickness were determined by MRI after two years of intervention [183].”
BackgroundAZOULAY-ZOHAR, H., ISRAELSON, A., ABU-HAMAD, S., & SHOSHAN-BARMATZ, V. (2004) · Biochemical Journal · doi:10.1042/bj20031465 · Cited by 408 · cited 1×
“The hexokinase isoform HK-I binds to the N-terminus of VDAC1 on the cytoplasmic side of the outer mitochondrial membrane and has been shown in both in vitro and in vivo systems to protect against apoptosis [105,106].”
BackgroundButterfield, D. A., & Boyd-Kimball, D. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170543 · Cited by 403 · cited 1×
“These observations are consistent with our hypothesis that Aβ-oligomer-induced oxidative stress impairs glucose metabolism, contributing to mitochondrial dysfunction, leading to synaptic dysfunction, and eventually resulting in neuronal death (Figure 4) [8,142].”
ResultSelf-citationReddy, P. H., Tripathi, R., Troung, Q., Tirumala, K., Reddy, T. P., Anekonda, V., Shirendeb, U. P., Calkins, M. J., Reddy, A. P., Mao, P., et al. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.10.011 · Cited by 394 · cited 3×
“Consistent with the hypothesis that both oxidative stress and mitochondrial dysfunction are early events in the progression of AD [12,35,53], many of the oxidized”
BackgroundChapter 7 Protein Oxidation Processes in Aging Brain
Butterfield, D. A., & Stadtman, E. R. (1997) · Advances in cell aging and gerontology · doi:10.1016/s1566-3124(08)60057-7 · Cited by 390
Self-citationSOD2 in mitochondrial dysfunction and neurodegeneration
Flynn, J. M., & Melov, S. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.05.027 · Cited by 390
Cell biology of the mitochondrion
van der Bliek, A. M., Sedensky, M. M., & Morgan, P. G. (2017) · Genetics · doi:10.1534/genetics.117.300262 · Cited by 388
Drake, J. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00225-7 · Cited by 371
Fueling thought: Management of glycolysis and oxidative phosphorylation in neuronal metabolism
Yellen, G. (2018) · Journal of Cell Biology · doi:10.1083/jcb.201803152 · Cited by 371 · cited 2×
“Rather, neurons rely on the tricarboxylic acid cycle and oxidative phosphorylation housed in mitochondria to produce ATP [72,120].”
BackgroundIdentification of nitrated proteins in Alzheimer’s disease brain using a redox proteomics approach
Sultana, R., Poon, H. F., Cai, J., Pierce, W. M., Merchant, M., Klein, J. B., Markesbery, W. R., & Butterfield, D. A. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.10.004 · Cited by 364 · cited 3×
“The voltage-dependent anion channel 1 (VDAC1), located in the outer mitochondrial membrane, regulates mitochondrial membrane permeability [94] and is significantly nitrated in late AD hippocampus [57].”
BackgroundSelf-citationHippocampal hypometabolism predicts cognitive decline from normal aging
Mosconi, L., De Santi, S., Li, J., Tsui, W. H., Li, Y., Boppana, M., Laska, E., Rusinek, H., & de Leon, M. J. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.12.008 · Cited by 360
Manganese Superoxide Dismutase: Guardian of the Powerhouse
Holley, A. K., Bakthavatchalu, V., Velez-Roman, J. M., & St. Clair, D. K. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12107114 · Cited by 358
Advances in Alzheimer's disease
Katzman, R., & Saitoh, T. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.3.2001787 · Cited by 357 · cited 2×
“In the United States, nearly six million persons have AD, with projections of between 15–20 million persons predicted to have AD within 30 years due to the aged-related nature of AD coupled to the very large Baby Boomer population in the USA (estimated to be up to 75 million Americans) [1].”
BackgroundOda, T., Wals, P., Osterburg, H. H., Johnson, S. A., Pasinetti, G. M., Morgan, T. E., Rozovsky, I., Stine, W. B., Snyder, S. W., Holzman, T. F., et al. (1995) · Experimental Neurology · doi:10.1006/exnr.1995.1080 · Cited by 352
Manczak, M., & Reddy, P. H. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds360 · Cited by 348 · cited 1×
“VDAC1 overexpression, which favors oligomerization and promotes apoptosis [103], is present in AD brain and increases as the disease progresses [104].”
BackgroundBosetti, F. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00314-1 · Cited by 348
Vagelatos, N. T., & Eslick, G. D. (2013) · Epidemiologic Reviews · doi:10.1093/epirev/mxs012 · Cited by 320
Multiple Functions and Regulation of Mammalian Peroxiredoxins
Rhee, S. G., & Kil, I. S. (2017) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060815-014431 · Cited by 319 · cited 1×
“Other mitochondrial-related antioxidant systems include, among others, thioredoxin [18], peroxiredoxin 4 [19], glutathione peroxidase 4 [20], and methionine sulfoxide reductase A [21].”
BackgroundMarked changes in mitochondrial DNA deletion levels in Alzheimer brains
Corral-Debrinski, M., Horton, T., Lott, M. T., Shoffner, J. M., McKee, A. C., Beal, M. F., Graham, B. H., & Wallace, D. C. (1994) · Genomics · doi:10.1006/geno.1994.1525 · Cited by 309 · cited 1×
“Mitochondrial oxidative stress is increased by the consumption of excess calories and, in turn, it leads to mitochondrial DNA damage [120], which has been described in an AD brain [169,170] in which base deletions correlate with complex IV deficiency in an AD hippocampus [171].”
BackgroundMalate dehydrogenases--structure and function.
Minárik, P., Tomášková, N., Kollárová, M., et al. (2002) · PubMed · Cited by 309
Oxidative stress, protein modification and Alzheimer disease
Tramutola, A., Lanzillotta, C., Perluigi, M., & Butterfield, D. A. (2017) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.06.005 · Cited by 303
Self-citationVDAC1, mitochondrial dysfunction, and Alzheimer’s disease
Shoshan-Barmatz, V., Nahon-Crystal, E., Shteinfer-Kuzmine, A., & Gupta, R. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.03.010 · Cited by 286 · cited 2×
“The voltage-dependent anion channel 1 (VDAC1), located in the outer mitochondrial membrane, regulates mitochondrial membrane permeability [94] and is significantly nitrated in late AD hippocampus [57].”
BackgroundAlzheimer’s disease-related alterations in synaptic density: neocortex and hippocampus.
Scheff, S. W., & Price, D. A. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-9s312 · Cited by 284
Cytochrome c oxidase is decreased in Alzheimer’s disease platelets
Cardoso, S. M., Proença, M. T., Santos, S., Santana, I., & Oliveira, C. R. (2004) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00033-2 · Cited by 281
Abu-Hamad, S., Zaid, H., Israelson, A., Nahon, E., & Shoshan-Barmatz, V. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708216200 · Cited by 278 · cited 1×
“The hexokinase isoform HK-I binds to the N-terminus of VDAC1 on the cytoplasmic side of the outer mitochondrial membrane and has been shown in both in vitro and in vivo systems to protect against apoptosis [105,106].”
BackgroundFalkowska, A., Gutowska, I., Goschorska, M., Nowacki, P., Chlubek, D., & Baranowska-Bosiacka, I. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161125939 · Cited by 277
Albanese, E., Launer, L. J., Egger, M., Prince, M. J., Giannakopoulos, P., Wolters, F. J., & Egan, K. (2017) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2017.05.007 · Cited by 272
Subramaniam, R., Roediger, F., Jordan, B., Mattson, M. P., Keller, J. N., Waeg, G., & Butterfield, D. A. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69031161.x · Cited by 270 · cited 1×
“Protein conformation is also altered with loss of function by HNE that binds to and changes the structure of proteins [28].”
BackgroundSelf-citationLi, S., & Selkoe, D. J. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15007 · Cited by 263
Sultana, R., Perluigi, M., & Butterfield, D. A. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.2021 · Cited by 262
Self-citationPhysical Activity and Alzheimer’s Disease: A Systematic Review
Stephen, R., Hongisto, K., Solomon, A., & Lönnroos, E. (2017) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glw251 · Cited by 262
Baek, S. H., Park, S. J., Jeong, J. I., Kim, S. H., Han, J., Kyung, J. W., Baik, S.-H., Choi, Y., Choi, B. Y., Park, J. S., et al. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.2385-16.2017 · Cited by 258 · cited 1×
“The inhibition of mitochondrial fission with mitochondrial division inhibitor-1 (Mdivi-1), which indirectly inhibited Drp-1, protected against the production of reactive oxygen species (ROS), loss of anterograde mitochondrial transport, damage to synapses, neuronal death, and stunted growth of neuritic spines, all of…”
BackgroundCroteau, E., Castellano, C. A., Fortier, M., Bocti, C., Fulop, T., Paquet, N., & Cunnane, S. C. (2018) · Experimental Gerontology · doi:10.1016/j.exger.2017.07.004 · Cited by 258 · cited 1×
“Unlike glucose metabolism, ketone metabolism does not appear to be altered in the early progression of AD, as ketones are used at the same rate in MCI and early AD as in the control brain [122,123].”
BackgroundReed, T., Perluigi, M., Sultana, R., Pierce, W. M., Klein, J. B., Turner, D. M., Coccia, R., Markesbery, W. R., & Butterfield, D. A. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.12.007 · Cited by 257 · cited 5×
“Both HSP70 and HSP90 are significantly carbonylated in MCI IPL [59,60], while HSP70 is modified by both HNE and 3-NT in an MCI hippocampus [56,58].”
BackgroundInfluentialSelf-citationZhao, Y., Chaiswing, L., Velez, J. M., Batinic-Haberle, I., Colburn, N. H., Oberley, T. D., & St. Clair, D. K. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3835 · Cited by 245 · cited 1×
“MnSOD activity is suppressed by the binding of p53 [85].”
BackgroundNeuropathologic Alterations in Mild Cognitive Impairment: A Review
Markesbery, W. R. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1220 · Cited by 236 · cited 1×
“Pathology in MCI is similar to that in AD, albeit to a somewhat lesser extent [7].”
ResultMidlife and Late-Life Blood Pressure and Dementia in Japanese Elderly: The Hisayama Study
Ninomiya, T., Ohara, T., Hirakawa, Y., Yoshida, D., Doi, Y., Hata, J., Kanba, S., Iwaki, T., & Kiyohara, Y. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.163055 · Cited by 230
Perluigi, M., Coccia, R., & Butterfield, D. A. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4406 · Cited by 229
Abu-Hamad, S., Arbel, N., Calo, D., Arzoine, L., Israelson, A., Keinan, N., Ben-Romano, R., Friedman, O., & Shoshan-Barmatz, V. (2009) · Journal of Cell Science · doi:10.1242/jcs.040188 · Cited by 226
Cooper, A., & Jeitner, T. (2016) · Biomolecules · doi:10.3390/biom6020016 · Cited by 223 · cited 1×
“Glutamate and glutamine are the most abundant amino acids in the human brain [129].”
BackgroundNelson, S. K., Bose, S. K., Grunwald, G. K., Myhill, P., & McCord, J. M. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.08.043 · Cited by 215
Solomon, A., Turunen, H., Ngandu, T., Peltonen, M., Levälahti, E., Helisalmi, S., Antikainen, R., Bäckman, L., Hänninen, T., Jula, A., et al. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2017.4365 · Cited by 213
Physical Activity, Brain Volume, and Dementia Risk: The Framingham Study
Tan, Z. S., Spartano, N. L., Beiser, A. S., DeCarli, C., Auerbach, S. H., Vasan, R. S., & Seshadri, S. (2016) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glw130 · Cited by 212
Mild Cognitive Impairment: Current Research and Clinical Implications
Petersen, R. (2007) · Seminars in Neurology · doi:10.1055/s-2006-956752 · Cited by 208 · cited 1×
“independent observer with otherwise normal activities of daily living [6].”
BackgroundThe energetic brain—A review from students to students
Bordone, M. P., Salman, M. M., Titus, H. E., Amini, E., Andersen, J. V., Chakraborti, B., Diuba, A. V., Dubouskaya, T. G., Ehrke, E., Espindola de Freitas, A., et al. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14829 · Cited by 205 · cited 1×
“In the brain, ATP is required for neurotransmitter synthesis, protein turnover, neurotransmission, transport, and maintenance of ion gradients [119].”
BackgroundOpii, W. O., Joshi, G., Head, E., Milgram, N. W., Muggenburg, B. A., Klein, J. B., Pierce, W. M., Cotman, C. W., & Butterfield, D. A. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.09.012 · Cited by 202 · cited 1×
“Alpha-lipoic acid is a cofactor for pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase, which are key components in glucose metabolism; when given to dogs and rodents, it decreases oxidative damage in the brain and improves cognition [149,150].”
BackgroundSelf-citationMetabolite profiling for the identification of altered metabolic pathways in Alzheimer's disease
González-Domínguez, R., García-Barrera, T., & Gómez-Ariza, J. L. (2015) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2014.10.010 · Cited by 200
Perluigi, M., Sultana, R., Cenini, G., Di Domenico, F., Memo, M., Pierce, W. M., Coccia, R., & Butterfield, D. A. (2009) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200800161 · Cited by 196 · cited 9×
“MnSOD is oxidatively modified by HNE in early AD IPL, resulting in a significant decrease in enzyme activity [55] and is also oxidatively modified by HNE in late AD IPL [54].”
BackgroundInfluentialSelf-citationHashimoto, T., Hussien, R., Cho, H.-S., Kaufer, D., & Brooks, G. A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002915 · Cited by 196 · cited 2×
“Lactate dehydrogenase-B (LDH) is also present in mitochondria [67] and is oxidatively modified by HNE in MCI hippocampus [56].”
BackgroundManganese superoxide dismutase regulation and cancer
Dhar, S. K., & St. Clair, D. K. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.03.009 · Cited by 196 · cited 2×
“As electron flow occurs in the multiple redox-sensitive proteins within Complex I on the inner membrane, electron leak occurs, usually in the form of superoxide radical anion or the hydrogendioxide radical, elevating oxidative stress (Figure 1) [8,16,17].”
BackgroundLushchak, O. V., Piroddi, M., Galli, F., & Lushchak, V. I. (2014) · Redox Report · doi:10.1179/1351000213y.0000000073 · Cited by 196 · cited 1×
“Aconitase is an iron–sulfur protein that catalyzes the interconversion of citrate and isocitrate [62] and is a redox-sensitive enzyme that is significantly modified by HNE in late AD hippocampus [54] and by carbonylation induced by Aβ in vivo [63].”
BackgroundReed, T. T., Pierce, W. M., Markesbery, W. R., & Butterfield, D. A. (2009) · Brain Research · doi:10.1016/j.brainres.2009.04.009 · Cited by 190 · cited 11×
“MnSOD is oxidatively modified by HNE in early AD IPL, resulting in a significant decrease in enzyme activity [55] and is also oxidatively modified by HNE in late AD IPL [54].”
BackgroundInfluentialCognitive and physical activity and dementia: A 44-year longitudinal population study of women
Najar, J., Östling, S., Gudmundsson, P., Sundh, V., Johansson, L., Kern, S., Guo, X., Hällström, T., & Skoog, I. (2019) · Neurology · doi:10.1212/wnl.0000000000007021 · Cited by 189
Alpha-lipoic acid as a new treatment option for Azheimer type dementia
Hager, K., Marahrens, A., Kenklies, M., Riederer, P., & Münch, G. (2001) · Archives of Gerontology and Geriatrics · doi:10.1016/s0167-4943(01)00104-2 · Cited by 188
Apolipoprotein E and oxidative stress in brain with relevance to Alzheimer's disease
Butterfield, D. A., & Mattson, M. P. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104795 · Cited by 188 · cited 2×
“It is conceivable that the studies of Mahely [31] and Butterfield [33] have significant overlap, although other studies would be required to test this notion.”
Self-citationAmino acid catabolism in Alzheimer’s disease brain: Friend or foe?
Griffin, J. W. D., & Bradshaw, P. C. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/5472792 · Cited by 185
Redox proteomics: from protein modifications to cellular dysfunction and disease
Butterfield, D. A., & Dalle‐Donne, I. (2014) · Mass Spectrometry Reviews · doi:10.1002/mas.21404 · Cited by 182 · cited 1×
“Redox proteomics is a subset of proteomics methods used to identify oxidatively or nitrosatively modified proteins [43].”
MethodSelf-citationReciprocal down-regulation of p53 and SOD2 gene expression-implication in p53 mediated apoptosis
Drane, P., Bravard, A., Bouvard, V., & May, E. (2001) · Oncogene · doi:10.1038/sj.onc.1204101 · Cited by 180 · cited 8×
“MnSOD is oxidatively modified by HNE in early AD IPL, resulting in a significant decrease in enzyme activity [55] and is also oxidatively modified by HNE in late AD IPL [54].”
BackgroundInfluentialDeBalsi, K. L., Hoff, K. E., & Copeland, W. C. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2016.04.006 · Cited by 180 · cited 2×
“The oxidation of EF-Tu could lead to altered function and the incorrect translation of mitochondrial proteins, which include 13 components of the electron transport chain [78].”
BackgroundMediation of the antiapoptotic activity of Bcl-xL protein upon interaction with VDAC1 protein
Arbel, N., Ben-Hail, D., & Shoshan-Barmatz, V. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.345918 · Cited by 179
Hardman, R. J., Kennedy, G., Macpherson, H., Scholey, A. B., & Pipingas, A. (2016) · Frontiers in Nutrition · doi:10.3389/fnut.2016.00022 · Cited by 179
Inhibition of mitochondrial fragmentation protects against Alzheimer’s disease in rodent model
Wang, W., Yin, J., Ma, X., Zhao, F., Siedlak, S. L., Wang, Z., Torres, S., Fujioka, H., Xu, Y., Perry, G., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx299 · Cited by 175 · cited 1×
“The inhibition of mitochondrial fission with mitochondrial division inhibitor-1 (Mdivi-1), which indirectly inhibited Drp-1, protected against the production of reactive oxygen species (ROS), loss of anterograde mitochondrial transport, damage to synapses, neuronal death, and stunted growth of neuritic spines, all of…”
BackgroundDiverting Glycolysis to Combat Oxidative Stress
Mullarky, E., & Cantley, L. C. (2015) · Innovative Medicine · doi:10.1007/978-4-431-55651-0_1 · Cited by 172 · cited 1×
“Under oxidative stress, glucose in the brain is not only needed to produce ATP, but it would be diverted to produce much needed NADPH via the pentose phosphate pathway to replenish thiol-containing antioxidants such as thioredoxin, peroxiredoxin, and glutathione, as the oxidative reactions that produce NADPH are irrev…”
BackgroundVDAC1 at the crossroads of cell metabolism, apoptosis and cell stress
Shoshan-Barmatz, V., N. Maldonado, E., & Krelin, Y. (2017) · Cell Stress · doi:10.15698/cst2017.10.104 · Cited by 170 · cited 1×
“Thus, VDAC1 mediates communication and traffic between mitochondria and the cytosol [95].”
Redox Proteomics in Selected Neurodegenerative Disorders: From Its Infancy to Future Applications
Butterfield, D. A., Perluigi, M., Reed, T., Muharib, T., Hughes, C. P., Robinson, R. A. S., & Sultana, R. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4109 · Cited by 168
Self-citationArbel, N., & Shoshan-Barmatz, V. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.082990 · Cited by 168
Aberrant protein S-nitrosylation contributes to the pathophysiology of neurodegenerative diseases
Nakamura, T., Prikhodko, O. A., Pirie, E., Nagar, S., Akhtar, M. W., Oh, C.-K., McKercher, S. R., Ambasudhan, R., Okamoto, S.-I., & Lipton, S. A. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.03.017 · Cited by 165
Physical Activity and Alzheimer Disease: A Protective Association
Santos-Lozano, A., Pareja-Galeano, H., Sanchis-Gomar, F., Quindós-Rubial, M., Fiuza-Luces, C., Cristi-Montero, C., Emanuele, E., Garatachea, N., & Lucia, A. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2016.04.024 · Cited by 164 · cited 1×
“While age, chromosomal sex, family history, and apoE genotype remain the primary risk factors for the development of AD [154,155], there are several controllable risk factors including obesity [156,157], hyperlipidemia [158,159], hypertension [160–163], type 2 diabetes [164–167], and sedentary lifestyle [168] that can…”
BackgroundGandhi, G. K., Cruz, N. F., Ball, K. K., & Dienel, G. A. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06333.x · Cited by 162
Wu, W., Brickman, A. M., Luchsinger, J., Ferrazzano, P., Pichiule, P., Yoshita, M., Brown, T., DeCarli, C., Barnes, C. A., Mayeux, R., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21557 · Cited by 162
Terni, B., Boada, J., Portero‐Otin, M., Pamplona, R., & Ferrer, I. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00266.x · Cited by 159 · cited 1×
“These include the tricarboxylic acid cycle enzymes aconitase in late AD [54] and malate dehydrogenase (MDH) in early AD [55] and the alpha-subunit of ATP synthase, or complex V of the electron transport chain, in MCI [56], early AD [55,61], and late AD [54,57].”
BackgroundShi, Y., Chen, J., Weng, C., Chen, R., Zheng, Y., Chen, Q., & Tang, H. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00871-4 · Cited by 158
Polis, B., & Samson, A. O. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.274328 · Cited by 154
Meng, X.-F., Yu, J.-T., Wang, H.-F., Tan, M.-S., Wang, C., Tan, C.-C., & Tan, L. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140954 · Cited by 150
Carvalho, C., Santos, M. S., Oliveira, C. R., & Moreira, P. I. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.05.001 · Cited by 145
Smilansky, A., Dangoor, L., Nakdimon, I., Ben-Hail, D., Mizrachi, D., & Shoshan-Barmatz, V. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.691493 · Cited by 143 · cited 1×
“Aβ(1–42) also directly interacts with the N-terminus of VDAC1 and induces HKI release, resulting in VDAC1 oligomerization, cytochrome c release, and apoptosis in SH-SY5Y cells [107].”
BackgroundBioenergetic Origins of Complexity and Disease
Wallace, D. C. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2011.76.010462 · Cited by 141 · cited 1×
“ATP synthase utilizes the protein gradient established across the inner mitochondrial membrane by the electron transport chain to drive the phosphorylation of ADP to yield ATP [71,72].”
BackgroundKetogenic Medium Chain Triglycerides Increase Brain Energy Metabolism in Alzheimer’s Disease
Croteau, E., Castellano, C.-A., Richard, M. A., Fortier, M., Nugent, S., Lepage, M., Duchesne, S., Whittingstall, K., Turcotte, É. E., Bocti, C., et al. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-180202 · Cited by 135
APOE-amyloid interaction: Therapeutic targets
Wisniewski, T., & Drummond, E. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104784 · Cited by 131 · cited 1×
“Since the structure of apoE4 is different, due to the lack of Cys residues, compared to two key Cys residues in apoE2 and one key Cys residue in apoE3 [32], apoE4 is subject to proteolysis.”
BackgroundButterfield, D. A. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.06.006 · Cited by 126
Self-citationSultana, R., Perluigi, M., Newman, S. F., Pierce, W. M., Cini, C., Coccia, R., & Butterfield, D. A. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2810 · Cited by 125 · cited 7×
“MnSOD is oxidatively modified by HNE in early AD IPL, resulting in a significant decrease in enzyme activity [55] and is also oxidatively modified by HNE in late AD IPL [54].”
BackgroundInfluentialSelf-citationManganese superoxide dismutase: Beyond life and death
Holley, A. K., Dhar, S. K., Xu, Y., & St. Clair, D. K. (2012) · Amino Acids · doi:10.1007/s00726-010-0600-9 · Cited by 122
Oxidative modification of lipoic acid by HNE in Alzheimer disease brain
Hardas, S. S., Sultana, R., Clark, A. M., Beckett, T. L., Szweda, L. I., Murphy, M. P., & Butterfield, D. A. (2013) · Redox Biology · doi:10.1016/j.redox.2013.01.002 · Cited by 120
Self-citationMolecular Basis of Alzheimer’s Disease: Focus on Mitochondria
Oliver, D. M. A., & Reddy, P. H. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190048 · Cited by 120
On the central role of mitochondria dysfunction and oxidative stress in Alzheimer’s disease
Tobore, T. O. (2019) · Neurological Sciences · doi:10.1007/s10072-019-03863-x · Cited by 120 · cited 1×
“Based on the hypothesis that Aβ-induced oxidative damage to mitochondria is an early event in the progression of AD, mitochondria have been targeted for the study and development of therapeutics [53,147,148].”
BackgroundMass spectrometry and redox proteomics: Applications in disease
Butterfield, D. A., Gu, L., Domenico, F. D., & Robinson, R. A. S. (2013) · Mass Spectrometry Reviews · doi:10.1002/mas.21374 · Cited by 119 · cited 1×
“For much more detailed descriptions of the methods involved in redox proteomics, the reader is referred to a descriptive analytical review paper [46].”
BackgroundSelf-citationCenini, G., Sultana, R., Memo, M., & Butterfield, D. A. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00163.x · Cited by 117 · cited 7×
“MnSOD is oxidatively modified by HNE in early AD IPL, resulting in a significant decrease in enzyme activity [55] and is also oxidatively modified by HNE in late AD IPL [54].”
BackgroundInfluentialSelf-citationButterfield, D. A., Domenico, F. D., Swomley, A. M., Head, E., & Perluigi, M. (2014) · Biochemical Journal · doi:10.1042/bj20140772 · Cited by 116
Self-citationMaracci, C., & Rodnina, M. V. (2016) · Biopolymers · doi:10.1002/bip.22832 · Cited by 116 · cited 1×
“EF-Tu is a mitochondrial elongation factor responsible for coordinating the binding of amino acyl-tRNA to the codon [79] and is significantly modified by the lipid peroxidation product HNE in MCI IPL [56].”
Backgroundfor the FINGER study group, Stephen, R., Liu, Y., Ngandu, T., Antikainen, R., Hulkkonen, J., Koikkalainen, J., Kemppainen, N., Lötjönen, J., Levälahti, E., et al. (2019) · Alzheimer's Research & Therapy · doi:10.1186/s13195-019-0506-z · Cited by 116
Reddy, P. H., Manczak, M., & Yin, X. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170051 · Cited by 116
Di Domenico, F., Barone, E., Perluigi, M., & Butterfield, D. A. (2017) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6759 · Cited by 114
Self-citationSultana, R., Mecocci, P., Mangialasche, F., Cecchetti, R., Baglioni, M., & Butterfield, D. A. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-101425 · Cited by 111 · cited 3×
“Moreover, mitochondria isolated from lymphocytes from persons with AD and MCI showed elevated oxidative damage that correlated inversely with cognitive performance [36,37].”
BackgroundSelf-citationYang, X., Yang, Y., Li, G., Wang, J., & Yang, E. S. (2008) · Journal of Molecular Neuroscience · doi:10.1007/s12031-007-9033-7 · Cited by 111 · cited 1×
“CoQ10 led to decreased Aβ pathology in aged transgenic mice with human AD presenilin-1 mutation, and in a different study, a quinonecontaining derivative of CoQ10 (MitoQ) that targets mitochondria, improved memory, and neuropathology in a transgenic mouse model of AD [152,153].”
BackgroundPhysical Exercise and Brain Mitochondrial Fitness: The Possible Role Against Alzheimer's Disease
Bernardo, T. C., Marques‐Aleixo, I., Beleza, J., Oliveira, P. J., Ascensão, A., & Magalhães, J. (2016) · Brain Pathology · doi:10.1111/bpa.12403 · Cited by 108
Dhar, S. K., Tangpong, J., Chaiswing, L., Oberley, T. D., & St. Clair, D. K. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1233 · Cited by 106 · cited 8×
“MnSOD is oxidatively modified by HNE in early AD IPL, resulting in a significant decrease in enzyme activity [55] and is also oxidatively modified by HNE in late AD IPL [54].”
BackgroundInfluentialGeula, S., Ben-Hail, D., & Shoshan-Barmatz, V. (2012) · Biochemical Journal · doi:10.1042/bj20112079 · Cited by 105
Redox proteomics and amyloid β-peptide: Insights into Alzheimer disease
Butterfield, D. A., & Boyd‐Kimball, D. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14589 · Cited by 105 · cited 5×
“Consistent with the hypothesis that both oxidative stress and mitochondrial dysfunction are early events in the progression of AD [12,35,53], many of the oxidized”
BackgroundInfluentialSelf-citationAPOE alters glucose flux through central carbon pathways in astrocytes
Williams, H. C., Farmer, B. C., Piron, M. A., Walsh, A. E., Bruntz, R. C., Gentry, M. S., Sun, R. C., & Johnson, L. A. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104742 · Cited by 105 · cited 1×
“Compared to the apoE2 or apoE3 isoforms, astrocytes expressing the apoE4 isoform exhibited increased lactate synthesis, pentose phosphate pathway flux, and gluconeogenesis [127].”
BackgroundBoyd-Kimball, D., Poon, H. F., Lynn, B. C., Cai, J., Pierce Jr., W. M., Klein, J. B., Ferguson, J., Link, C. D., & Butterfield, D. A. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.07.001 · Cited by 98 · cited 1×
“MDH is oxidatively modified by HNE in early AD inferior parietal lobule (IPL) [55] and its carbonylation is induced by Aβ in vitro and in vivo [63,65,66].”
BackgroundStructure-based Analysis of VDAC1 Protein
Geula, S., Naveed, H., Liang, J., & Shoshan-Barmatz, V. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.268920 · Cited by 97
Mitochondrial DNA deletions cause the biochemical defect observed in Alzheimer’s disease
Krishnan, K. J., Ratnaike, T. E., De Gruyter, H. L. M., Jaros, E., & Turnbull, D. M. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.08.009 · Cited by 95 · cited 1×
“Mitochondrial oxidative stress is increased by the consumption of excess calories and, in turn, it leads to mitochondrial DNA damage [120], which has been described in an AD brain [169,170] in which base deletions correlate with complex IV deficiency in an AD hippocampus [171].”
BackgroundAluise, C. D., Robinson, R. A. S., Cai, J., Pierce, W. M., Markesbery, W. R., & Butterfield, D. A. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-101083 · Cited by 94 · cited 6×
“MnSOD is oxidatively modified by HNE in early AD IPL, resulting in a significant decrease in enzyme activity [55] and is also oxidatively modified by HNE in late AD IPL [54].”
BackgroundInfluentialSelf-citationp53 and mitochondrial dysfunction: novel insight of neurodegenerative diseases
Dai, C.-Q., Luo, T.-T., Luo, S.-C., Wang, J.-Q., Wang, S.-M., Bai, Y.-H., Yang, Y.-L., & Wang, Y.-Y. (2016) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-016-9669-5 · Cited by 93
Differential S-nitrosylation of proteins in Alzheimer’s disease
Zahid, S., Khan, R., Oellerich, M., Ahmed, N., & Asif, A. R. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2013.10.026 · Cited by 91
Cerebral gluconeogenesis and diseases
Yip, J., Geng, X., Shen, J., & Ding, Y. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00521 · Cited by 89 · cited 2×
“Glutamine is produced from glutamate by the activity of glutamine synthetase (GS) [124,131].”
BackgroundRen, X., Keeney, J. T. R., Miriyala, S., Noel, T., Powell, D. K., Chaiswing, L., Bondada, S., St. Clair, D. K., & Butterfield, D. A. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.12.029 · Cited by 88
Self-citationSultana, R., Reed, T., Perluigi, M., Coccia, R., Pierce, W. M., & Butterfield, D. A. (2007) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00065.x · Cited by 87 · cited 1×
“Both HSP70 and HSP90 are significantly carbonylated in MCI IPL [59,60], while HSP70 is modified by both HNE and 3-NT in an MCI hippocampus [56,58].”
BackgroundSelf-citationTyrosine-nitrated proteins: Proteomic and bioanalytical aspects
Batthyány, C., Bartesaghi, S., Mastrogiovanni, M., Lima, A., Demicheli, V., & Radi, R. (2017) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6787 · Cited by 86 · cited 1×
“This modification can provide detrimental consequences for cell survival [8,13,29,30].”
BackgroundVDAC1-interacting anion transport inhibitors inhibit VDAC1 oligomerization and apoptosis
Ben-Hail, D., & Shoshan-Barmatz, V. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.04.002 · Cited by 80 · cited 1×
“VDAC1 inhibitors prevent oligomerization and the induction of apoptosis even in the presence of pro-apoptotic stimuli [102], indicating that apoptotic induction can be driven by VDAC1 oligomerization.”
BackgroundVDAC1 as a Player in Mitochondria-Mediated Apoptosis and Target for Modulating Apoptosis
Shoshan‐Barmatz, V., Krelin, Y., & Chen, Q. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867324666170616105200 · Cited by 80 · cited 1×
“VDAC1 overexpression, which favors oligomerization and promotes apoptosis [103], is present in AD brain and increases as the disease progresses [104].”
BackgroundCenini, G., Sultana, R., Memo, M., & Butterfield, D. A. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.03.015 · Cited by 79
Self-citationOgino, E., Manly, J. J., Schupf, N., Mayeux, R., & Gu, Y. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.07.013 · Cited by 78
Targeting Mitochondria in Alzheimer Disease: Rationale and Perspectives
Lanzillotta, C., Domenico, F. D., Perluigi, M., & Butterfield, D. A. (2019) · CNS Drugs · doi:10.1007/s40263-019-00658-8 · Cited by 78 · cited 2×
“Toward this goal, a recent compilation of mitochondria-targeted therapeutic strategies for AD was published [148].”
BackgroundSelf-citationShen, L., Chen, C., Yang, A., Chen, Y., Liu, Q., & Ni, J. (2015) · Journal of Proteomics · doi:10.1016/j.jprot.2015.04.005 · Cited by 73 · cited 2×
“MDH is oxidatively modified by HNE in early AD inferior parietal lobule (IPL) [55] and its carbonylation is induced by Aβ in vitro and in vivo [63,65,66].”
BackgroundSultana, R., Baglioni, M., Cecchetti, R., Cai, J., Klein, J. B., Bastiani, P., Ruggiero, C., Mecocci, P., & Butterfield, D. A. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.08.001 · Cited by 64 · cited 4×
“These proteins can be categorized as involved in energetics, structural integrity, cell signaling, and antioxidant defense [37].”
BackgroundInfluentialSelf-citationRedox proteomics and the dynamic molecular landscape of the aging brain
Perluigi, M., Swomley, A. M., & Butterfield, D. A. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2013.12.005 · Cited by 64
Self-citationLambert, J.-C., Mann, D. M. A., Harris, J. M., Chartier-Harlin, M.-C., Cumming, A., Coates, J., Lemmon, H., StClair, D., Iwatsubo, T., & Lendon, C. (2001) · Journal of Medical Genetics · doi:10.1136/jmg.38.6.353 · Cited by 61
The Functions of the Mammalian Methionine Sulfoxide Reductase System and Related Diseases
Jiang, B., & Moskovitz, J. (2018) · Antioxidants · doi:10.3390/antiox7090122 · Cited by 60
(2006) · PubMed · Cited by 54
Etiology of type 2 diabetes and Alzheimer’s disease: Exploring the mitochondria
Silzer, T. K., & Phillips, N. R. (2018) · Mitochondrion · doi:10.1016/j.mito.2018.04.004 · Cited by 53
Mangialasche, F., Baglioni, M., Cecchetti, R., Kivipelto, M., Ruggiero, C., Piobbico, D., Kussmaul, L., Monastero, R., Brancorsini, S., & Mecocci, P. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142052 · Cited by 53 · cited 1×
“The activity of aconitase is significantly decreased in mitochondria from both MCI and AD lymphocytes [112].”
BackgroundSultana, R., Newman, S. F., Abdul, H. M., Cai, J., Pierce, W. M., Klein, J. B., Merchant, M., & Butterfield, D. A. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20876 · Cited by 53 · cited 1×
“MDH is oxidatively modified by HNE in early AD inferior parietal lobule (IPL) [55] and its carbonylation is induced by Aβ in vitro and in vivo [63,65,66].”
BackgroundSelf-citationMitochondrial Chaperones in the Brain: Safeguarding Brain Health and Metabolism?
Castro, J. P., Wardelmann, K., Grune, T., & Kleinridders, A. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00196 · Cited by 53 · cited 2×
“Mitostasis refers specifically to mitochondrial proteostasis [77].”
BackgroundThe electrophile responsive proteome: Integrating proteomics and lipidomics with cellular function
Higdon, A. N., Landar, A., Barnes, S., & Darley-Usmar, V. M. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4523 · Cited by 51
Sultana, R., Robinson, R. A. S., Di Domenico, F., Abdul, H. M., Clair, D. K. S., Markesbery, W. R., Cai, J., Pierce, W. M., & Butterfield, D. A. (2011) · Journal of Proteomics · doi:10.1016/j.jprot.2011.06.015 · Cited by 41 · cited 1×
“The carbonylation of ATP synthase is induced in vivo by Aβ [73], and it is significantly modified by HNE in MCI hippocampus and IPL [56], early AD IPL [55], and late AD IPL [54] in addition to being significantly nitrated in late AD hippocampus [57].”
BackgroundSelf-citationQuantitative proteomics of synaptosome S‐nitrosylation in Alzheimer’s disease
Wijasa, T. S., Sylvester, M., Brocke‐Ahmadinejad, N., Schwartz, S., Santarelli, F., Gieselmann, V., Klockgether, T., Brosseron, F., & Heneka, M. T. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.14870 · Cited by 41
Tramutola, A., Pupo, G., Di Domenico, F., Barone, E., Arena, A., Lanzillotta, C., Broekaart, D., Blarzino, C., Head, E., Butterfield, D. A., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-151105 · Cited by 40 · cited 1×
“This relationship is suggested to fine-tune the cellular response to oxidative and nitrosative stress [92], but oxidative damage to MnSOD and p53 in MCI and AD brain may affect this interplay, which contributes to apoptosis [93] and to the spread of ROS and subsequent oxidative damage beyond the subcellular localizati…”
BackgroundSelf-citationZaręba-Kozioł, M., Szwajda, A., Dadlez, M., Wysłouch-Cieszyńska, A., & Lalowski, M. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.036079 · Cited by 39
Ren, X., Hinchie, A., Swomley, A., Powell, D. K., & Butterfield, D. A. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.08.008 · Cited by 29
Evaluation of respiratory chain activity in lymphocytes of patients with Alzheimer disease
Feldhaus, P., Fraga, D. B., Ghedim, F. V., De Luca, R. D., Bruna, T. D., Heluany, M., Matos, M. P., Ferreira, G. K., Jeremias, I. C., Heluany, C., et al. (2011) · Metabolic Brain Disease · doi:10.1007/s11011-011-9253-y · Cited by 27 · cited 1×
“Consistent with a possible compensatory mechanism in the progression of the disease is a significant increase in the activity of electron transport chain complexes II and IV reported in mitochondria isolated from AD lymphocytes [108]; however, in mitochondria isolated from AD platelets, the activity of complex IV, or…”
BackgroundBarone, E., Cenini, G., Domenico, F. D., Noel, T. J., Wang, C., Perluigi, M., Clair, D. K. S., & Butterfield, D. A. (2015) · Journal of Neuroscience Research · doi:10.1002/jnr.23627 · Cited by 19 · cited 1×
“This relationship is suggested to fine-tune the cellular response to oxidative and nitrosative stress [92], but oxidative damage to MnSOD and p53 in MCI and AD brain may affect this interplay, which contributes to apoptosis [93] and to the spread of ROS and subsequent oxidative damage beyond the subcellular localizati…”
BackgroundSelf-citationFiorini, A., Sultana, R., Barone, E., Cenini, G., Perluigi, M., Mancuso, C., Cai, J., Klein, J. B., St. Clair, D., & Butterfield, D. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049846 · Cited by 16 · cited 1×
“Protein expression of MnSOD was significantly increased in mitochondria isolated from the brain of p53 knockout mice [89], which is consistent with the p53 transcriptional repression of MnSOD [90,91].”
BackgroundSelf-citation
Cited by
Perluigi, M., Di Domenico, F., & Butterfield, D. A. (2024) · Physiological Reviews · doi:10.1152/physrev.00030.2022 · Cited by 282
Self-citationChiaradia, E., Tancini, B., Emiliani, C., Delo, F., Pellegrino, R. M., Tognoloni, A., Urbanelli, L., & Buratta, S. (2021) · Cells · doi:10.3390/cells10071763 · Cited by 241
Deregulated mitochondrial microRNAs in Alzheimer's disease: Focus on synapse and mitochondria
Gowda, P., Reddy, P. H., & Kumar, S. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101529 · Cited by 163
Altered Metabolism in Alzheimer Disease Brain: Role of Oxidative Stress
Rummel, N. G., & Butterfield, D. A. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0177 · Cited by 118
“There is widespread agreement across many laboratories that oxidative stress is a key contributor to the pathogenesis and progression of AD (15, 17, 20–22, 90, 102, 114, 135).”
Self-citationÜremiş, N., & Üremiş, M. M. (2025) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70133 · Cited by 112
Metadata
- Authors
- Butterfield, D. A., & Boyd-Kimball, D.
- Affiliations
- University of Kentucky (US)
- Department of Chemistry and Biochemistry, University of Mount Union, Alliance, OH 44601, USA
- Corresponding author
- Butterfield, D. Allan
- Venue
- Antioxidants
- Publisher
- MDPI AG
- Published
- 2020-09-02
- Volume
- 9
- Issue
- 9
- Pages
- 818
- ISSN
- 2076-3921 (ISSN-L)
- PMC
- PMC7554713
- OpenAlex
- W3082151022
- Cited by
- 85
- References
- 192
- Citations by year
- 2026: 9 · 2025: 19 · 2024: 11 · 2023: 15 · 2022: 13 · 2021: 18
- FWCI
- 1.47
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Antioxidants (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UKnowledge (University of Kentucky) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health (AG060056)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, amnestic mild cognitive impairment, mitochondrial oxidative stress, nitrosative stress, mitochondria, redox proteomics, free radicals, oxidative modification, biomarkers, neuroimaging, therapeutic target
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.